MODIFIED CONCENTRIC MICROCATHETER

K111619 · Concentric Medical, Inc. · DQO · Jul 6, 2011 · Cardiovascular

Device Facts

Record IDK111619
Device NameMODIFIED CONCENTRIC MICROCATHETER
ApplicantConcentric Medical, Inc.
Product CodeDQO · Cardiovascular
Decision DateJul 6, 2011
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 870.1200
Device ClassClass 2

Intended Use

The Modified Concentric Microcatheter is indicated for use in the selective placement of fluids and/or other devices or agents into the peripheral, coronary and neuro vasculature during diagnostic and/or therapeutic procedures.

Device Story

Single lumen, braided, variable stiffness catheter; used for selective delivery of fluids, devices, or agents into peripheral, coronary, and neuro vasculature. Features luer hub for connection to rotating hemostasis valve; radiopaque shaft and distal marker for fluoroscopic visualization; hydrophilic coating to reduce friction. Operated by clinicians during diagnostic or therapeutic procedures. Provides access to vasculature; facilitates delivery of therapeutic agents or diagnostic materials.

Clinical Evidence

Bench testing only. No clinical data provided. Verification and validation testing included kink resistance, leak resistance, flexibility, flow, tensile, and torque testing. Biocompatibility testing (hemocompatibility, cytotoxicity, systemic toxicity, sensitization, irritation) was leveraged from the predicate device.

Technological Characteristics

Single lumen, braided, variable stiffness catheter. Features hydrophilic coating, luer hub, and radiopaque shaft/distal marker. Materials are identical to predicate device. No energy source or software components.

Indications for Use

Indicated for selective placement of fluids, devices, or agents into peripheral, coronary, and neuro vasculature during diagnostic or therapeutic procedures. No specific age or gender restrictions provided.

Regulatory Classification

Identification

An intravascular diagnostic catheter is a device used to record intracardiac pressures, to sample blood, and to introduce substances into the heart and vessels. Included in this generic device are right-heart catheters, left-heart catheters, and angiographic catheters, among others.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## 510(k) Summary | Trade Name: | Modified Concentric Microcatheter | |----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Common Name: | Diagnostic Intravascular Catheter | | Classification Name: | Diagnostic Intravascular Catheter, 21CFR 870.1200 – Class II | | Submitter | Concentric® Medical, Inc.<br>301 E. Evelyn Avenue<br>Mountain View, CA 94041<br>Tel 650-938-2100<br>Fax 650-237-5230<br>Facility Registration #2954917<br><br>Contact: Kirsten Valley, Senior Vice President, Technology and Regulatory Affairs | | Predicate Device | Concentric Microcatheter (K091961) | #### Device Description The Modified Concentric Microcatheter is a single lumen, braided, variable stiffness catheter designed for use in the selective placement of fluids and/or other devices or agents into the peripheral, coronary and neuro vasculature during diagnostic and/or therapeutic procedures. A luer hub on the proximal end of the shaft enables connection to the rotating hemostasis valve included in the package. The radiopaque shaft and distal marker facilitate fluoroscopic visualization. The catheter shaft is coated with a hydrophilic coating to reduce friction during use. #### Intended Use The Modified Concentric Microcatheter is indicated for use in the selective placement of fluids and/or other devices or agents into the peripheral, coronary and neuro vasculature during diagnostic and/or therapeutic procedures. #### Technological Characteristics The Modified Concentric Microcatheter has the same technological characteristics as the K091961 predicate device. The device design, materials used, function, physical properties and composition have not been changed. #### Testing Summary The results of verification and validation conducted on the Modified Concentric Microcatheter demonstrate that it performs as designed, is suitable for its intended use and is substantially equivalent to the predicate device. Specifically, the following tests were performed: {1}------------------------------------------------ - . Kink Resistance - the device's ability to withstand kinking when flexed was successfully evaluated. - . Leak Resistance – the device's leak resistance when subjected to both high pressure and vacuum was successfully evaluated. - . Flexibility Testing - the device's ability to navigate tight bends was successfully evaluated. - . Flow Testing - the device's ability to infuse fluids was succesfully evaluated. - . Tensile Testing - the device's mechanical integrity under tensile loads was successfully evaluated. - . Torque Testing - the device's mechanical integrity when subjected to torsion was successfully evaluated. The materials on the Modified Concentric Microcatheter are the same as the predicate device. As a result, the following biocompatibility tests were leveraged. - . Hemocompatibilty/Coagulation - . Cytotoxicity - Systemic Toxicity . - Hemocompatibility/Hematology . - . Sensitization - Irritation/Intracutaneous Reactivity . - . Pyrogen/Sytem.Toxicity ### Summary of Substantial Equivalence The Modified Concentric Microcatheter is substantially equivalent to the predicate device with regard to device design, intended use, and patient population. The results of verification and validation conducted on the Modified Concentric Microcatheter demonstrate that it performs as designed, is suitable for its intended use and is substantially equivalent to the predicate device. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its wing and body. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular fashion around the eagle. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 Concentric Medical, Inc. c/o Ms. Kristen Valley Senior Vice President, Technology and Regulatory Affairs 301 E. Evelyn Avenue Mountain View, CA 94041 JUL - 6 2011 Re: KI11619 Trade/Device Name: Modified Concentric Catheter Regulation Number: 21 CFR 870.1200 Regulation Name: Catheter, Intravascular, Diagnostic Regulatory Class: Class II Product Code: DQO Dated: June 9, 2011 Received: June 10, 2011 Dear Ms. Valley: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set {3}------------------------------------------------ Page 2 – Ms. Kristen Valley forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours, Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # Statement of Indications for Use ### INDICATIONS FOR USE | 510(k) Number (if known): | This application K111619 | |---------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Device Name: | Modified Concentric Microcatheter | | Indications for Use: | The Modified Concentric Microcatheter is<br>indicated for use in the selective placement of<br>fluids and/or other devices or agents into the<br>peripheral, coronary and neuro vasculature<br>during diagnostic and/or therapeutic<br>procedures. | Prescription Use __X (Per 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use_X (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) | Concurrence of CDRH, Office of Device Evaluation (ODE) | |--------------------------------------------------------| | (Division Sign-Off) | | Division of Cardiovascular Devices | 510(k) Number_(SII) 61) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%